BiotechTube

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Acne Vulgaris

Conditions

Acne Vulgaris

Trial Timeline

Apr 1, 2015 → Dec 1, 2015

NCT ID
NCT02465632

About Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% + Placebo

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% + Placebo is a phase 3 stage product being developed by Glenmark Pharmaceuticals for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT02465632. Target conditions include Acne Vulgaris.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02465632Phase 3Completed

Competing Products

20 competing products in Acne Vulgaris

See all competitors
ProductCompanyStageHype Score
Olumacostat Glasaretil Gel, 5.0%Eli LillyPhase 3
77
HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 PlaceboHoth TherapeuticsPhase 2
44
Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + PlaceboSun PharmaceuticalPhase 1
33
Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo ControlSun PharmaceuticalPhase 1
33
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test productSun PharmaceuticalPhase 1
33
Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical GelSun PharmaceuticalPhase 1
33
Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma)Sun PharmaceuticalPhase 1
33
Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories)Sun PharmaceuticalPhase 1
33
Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + PlaceboSun PharmaceuticalPhase 1
33
ADPS topical product + Placebo ControlSun PharmaceuticalPhase 2
52
IsotretinoinSun PharmaceuticalApproved
85
Winlevi (Clascoterone) cream 1%Sun PharmaceuticalApproved
85
Adapalene Gel 0.3% + Differin® + PlaceboSun PharmaceuticalPhase 1
33
CLPG Topical Gel 1% + Clindamycin + PlaceboSun PharmaceuticalPhase 1
33
Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + PlaceboSun PharmaceuticalPhase 1
33
Test. + Aczone Gel 5% + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin Phosphate + Clindamycin Phosphate RLD + PlacebosSun PharmaceuticalPhase 1
33
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo ControlSun PharmaceuticalPhase 1
33

Other Products from Glenmark Pharmaceuticals

Nitric OxidePhase 3
77
Fluticasone propionate Inhalation Aerosol 44 mcg + FLOVENT HFA 44 mcg + Matching Placebo inhalerPhase 3
77
Diclofenac Sodium gel, 1% + Voltaren® Gel + PlaceboPhase 3
77
Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064% + Enstilar® foam (LEO Pharma Inc.)Phase 3
77
Calcipotriene/Betamethasone Dipropionate + Taclonex® + PlaceboPhase 3
77